Results 1 to 10 of about 211,965 (305)

Trends in utilization and cost of triglyceride-lowering therapies among Medicare beneficiaries: An analysis from the Medicare part D database [PDF]

American Journal of Preventive Cardiology
Background: Approximately 14 million U.S. adults may benefit from treatment of hypertriglyceridemia to reduce risk of atherosclerotic cardiovascular disease (ASCVD).
Kabir Malkani, Ruina Zhang, Navjot Sobti, Krista Zachariah, Jacob Groenendyk, Subhanik Purkayastha, Xiaohan Ying, Danielle Newbury, Diala Steitieh, Sonika Patel, Vinay Kini   +10 more
doaj   +2 more sources

Pre-Medicare Eligible Individuals’ Decision-Making In Medicare Part D: An Interview Study [PDF]

INNOVATIONS in Pharmacy, 2010
ObjectivesThe objective of this study was to elicit salient beliefs among pre-Medicare eligible individuals regarding (1) the outcomes associated with enrolling in the Medicare Part D program; (2) those referents who might influence participants ...
Tao Jin, B.S. Pharm, Ph.D. Candidate, Richard R. Cline, Ph.D., Associate Professor, Ronald S. Hadsall, Ph.D., Professor   +2 more
doaj   +3 more sources

Impact of Medicare prescription drug (Part D) coverage expansion on utilisation and financial burden of benzodiazepines among older adults: an interrupted time series analysis

BMJ Open, 2021
Objective Benzodiazepines were excluded from Medicare Part D coverage since its introduction in 2006. Part D expanded coverage for benzodiazepines in 2013.
Minghui Li, Jing Yuan, Z Kevin Lu, Chelsea Dezfuli   +3 more
doaj   +1 more source

Medicare Part D [PDF]

JAMA, 2008
Medicare Part D Represents a bold experiment to publicly fund, but privately sell and administer, prescription drug insurance. Part D is only a relatively small part of the overall Medicare program; Medicare spent $432 billion overall in 2007, of which Part D accounted for only 11.6% ($50 billion).1 However, the Medicare program is so large that Part D
Dana P. Goldman, Geoffrey F. Joyce
openaire   +1 more source

Using journey mapping to understand the patient experience with selecting a Medicare part D plan using a pharmacy consultation service

Exploratory Research in Clinical and Social Pharmacy, 2021
Background: Patient experience with community pharmacy services can be informed by human-centered design principles and approaches. Pharmacy services may benefit from detailed evaluations of consumer experience and patient-centered service design ...
Logan T. Murry, Arwa Al-Khatib, Matthew J. Witry   +2 more
doaj   +1 more source

Geographic and socioeconomic disparities contribute to variation in opioid prescription patterns in the Medicare Part D population: A cross-sectional study [PDF]

JAAD International
Lauren N. McGrath, BA, Nathan Schedler, BS, BA, Sarah A. Martin, BS, Steven R. Feldman, MD, PhD   +3 more
doaj   +2 more sources

Cost-Savings and Patient Experience with a Pharmacy-Led Medicare Part D Consultation Service

INNOVATIONS in Pharmacy, 2020
Background: There are many Medicare Part D plans, making it difficult for patients to choose the optimal plan. The decision to remain on current Medicare plans is reinforced by patient inertia and uncertainty associated with plan-switching decisions.
Logan Murry, Brandon Gerleman, Huiwen Deng , Julie Urmie   +3 more
doaj   +1 more source

Medicare Part D plan-selection experience: qualitative findings from a national cross-sectional survey

Exploratory Research in Clinical and Social Pharmacy, 2023
Background: A variety of services exit to assist eligible beneficiaries select Medicare Part D insurance plans; however, selecting an optimal plan remains a challenge.
Logan T. Murry, Matthew J. Witry, Julie Urmie   +2 more
doaj   +1 more source

Important Things to Know about Medicare Chapter Five: Medicare Part D--Prescription Drug Coverage

EDIS, 2014
Important Things to Know about Medicare is a series of 10 publications that will cover the most common Medicare concerns. The series will provide general information about Medicare, including the four major plans, supplemental policies, interactions ...
Amanda Terminello, Martie Gillen
doaj   +5 more sources

Impact of the change of copay policy in Medicare Part D on zoster vaccine uptake among Medicare beneficiaries in a managed care organization

BMC Health Services Research, 2017
Background Kaiser Permanente Southern California (KPSC) adopted the Medicare Part D Tier-6 with zero patient copay for zoster vaccination in 2012. We assessed the impact of the implementation on zoster vaccination rate (GSK study identifier: HO-13-14,182)
Rulin C. Hechter, Lei Qian, Songkai Yan, Yi Luo, Girishanthy Krishnarajah, Hung-Fu Tseng   +5 more
doaj   +1 more source